119 related articles for article (PubMed ID: 1603473)
1. Analysis of immunoradiological properties of radiolabelled monoclonal antibody for tumour localization.
Boonkitticharoen V; Laohathai K
Nucl Med Commun; 1992 May; 13(5):342-8. PubMed ID: 1603473
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunodetection of gliomas by administration of radiolabelled monoclonal antibodies. Experimental data.
Stavrou D; Mellert W; Bilzer T; Senekowitsch R; Keiditsch E; Mehraein P
Anticancer Res; 1985; 5(2):147-56. PubMed ID: 3994308
[TBL] [Abstract][Full Text] [Related]
3. Site-specific conjugation of a radioiodinated phenethylamine derivative to a monoclonal antibody results in increased radioactivity localization in tumor.
Kurth M; Pèlegrin A; Rose K; Offord RE; Pochon S; Mach JP; Buchegger F
J Med Chem; 1993 Apr; 36(9):1255-61. PubMed ID: 8487262
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies for radioimmunodetection of tumours and for targeting.
Baldwin RW; Embleton MJ; Pimm MV
Bull Cancer; 1983; 70(2):132-6. PubMed ID: 6575842
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunotherapy of MCF7 breast cancer cell line with 131I-PR81 monoclonal antibody against MUC1: comparison of direct and indirect radioiodination methods.
Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Hasan ZM; Salouti M; Gandomkar M; Sadri K
Hum Antibodies; 2010; 19(1):15-25. PubMed ID: 20555127
[TBL] [Abstract][Full Text] [Related]
6. Comparative tumour localization properties of radiolabelled monoclonal antibody preparations of defined immunoreactivities.
Pimm MV; Baldwin RW
Eur J Nucl Med; 1987; 13(7):348-52. PubMed ID: 3428284
[TBL] [Abstract][Full Text] [Related]
7. Radiolabelled monoclonal antibodies in clinical and surgical oncology: a review.
Biassoni L; D'Andrea V; Biancari F; Santoni F; Dibra A; De Antoni E
Panminerva Med; 1997 Mar; 39(1):46-52. PubMed ID: 9175421
[TBL] [Abstract][Full Text] [Related]
8. Development of a method to measure kinetics of radiolabelled monoclonal antibody in human tumour with applications to microdosimetry: positron emission tomography studies of iodine-124 labelled 3F8 monoclonal antibody in glioma.
Daghighian F; Pentlow KS; Larson SM; Graham MC; DiResta GR; Yeh SD; Macapinlac H; Finn RD; Arbit E; Cheung NK
Eur J Nucl Med; 1993 May; 20(5):402-9. PubMed ID: 8519259
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies.
Behr TM; Béhé M; Löhr M; Sgouros G; Angerstein C; Wehrmann E; Nebendahl K; Becker W
Eur J Nucl Med; 2000 Jul; 27(7):753-65. PubMed ID: 10952487
[TBL] [Abstract][Full Text] [Related]
10. Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo.
Lahorte CM; Bacher K; Burvenich I; Coene ED; Cuvelier C; De Potter C; Thierens H; Van de Wiele C; Dierckx RA; Slegers G
J Nucl Med; 2004 Jun; 45(6):1065-73. PubMed ID: 15181142
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
[TBL] [Abstract][Full Text] [Related]
12. Radioiodination of murine anti-alpha-foetoprotein E.9 monoclonal antibody and its F(ab')2 fragment for the diagnosis of hepatocellular carcinoma.
Beyers M; Aspinall S; Conradie JD; Fourie PJ
Nuklearmedizin; 1988 Jun; 27(3):87-94. PubMed ID: 2457207
[TBL] [Abstract][Full Text] [Related]
13. Differences in tumour and normal tissue concentrations of iodine- and indium-labelled monoclonal antibody. I. The effect on image contrast in clinical studies.
Perkins AC; Pimm MV
Eur J Nucl Med; 1985; 11(8):295-9. PubMed ID: 4076237
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vivo study of 124I-labelled monoclonal antibody H17E2 in a human tumour xenograft model. A prelude to positron emission tomography (PET).
Snook DE; Rowlinson-Busza G; Sharma HL; Epenetos AA
Br J Cancer Suppl; 1990 Jul; 10():89-91. PubMed ID: 2383487
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic application of a radiolabelled monoclonal antibody in nude mice xenografted with human neuroblastoma: tumoricidal effects and distribution studies.
Jones DH; Goldman A; Gordon I; Pritchard J; Gregory BJ; Kemshead JT
Int J Cancer; 1985 Jun; 35(6):715-20. PubMed ID: 4008099
[TBL] [Abstract][Full Text] [Related]
16. A simple method to determine the immunoreactivity of radiolabelled monoclonal antibodies to the TAG-72 antigen.
Ngai WM; Reilly RM
Appl Radiat Isot; 1993 Sep; 44(9):1193-7. PubMed ID: 8401449
[TBL] [Abstract][Full Text] [Related]
17. Selective localisation of two radiolabelled anti-sarcoma monoclonal antibodies in human osteosarcoma xenografts.
Bruland O; Fodstad O; Skretting A; Pihl A
Br J Cancer; 1987 Jul; 56(1):21-5. PubMed ID: 3476143
[TBL] [Abstract][Full Text] [Related]
18. The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody.
Davidson BR; Babich J; Young H; Waddington W; Clarke G; Short M; Boulos P; Styles J; Dean C
Br J Cancer; 1991 Nov; 64(5):850-6. PubMed ID: 1931605
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
[TBL] [Abstract][Full Text] [Related]
20. Tumour localization and pharmacokinetics of iodine-125 human monoclonal IgM antibody (COU-1) and its monomeric and half-monomeric fragments analysed in nude mice grafted with human tumour.
Ditzel H; Rasmussen JW; Erb K; Jensenius JC
Eur J Nucl Med; 1992; 19(6):409-17. PubMed ID: 1618232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
